SSY Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LJUIF research report →
About the company
SSY Group Limited functions as an investment holding company, primarily focused on the research, development, manufacturing, and distribution of a wide array of pharmaceutical goods. Its products reach hospitals and distributors across the People's Republic of China and international markets. The company's extensive product portfolio encompasses various intravenous (IV) infusion solutions, including formulations in non-PVC soft bags, upright soft bags, robust PP plastic bottles, and traditional glass bottles.
- CEO
- Jiguang Qu
- IPO
- 2015
- Employees
- 6,146
- HQ
- Wan Chai, HK
Price Chart
- Market Cap
- $1.19B
- P/E
- 14.20
- P/S
- 1.59
- P/B
- 0.92
- EV/EBITDA
- 8.56
- Div Yield
- 3.49%
- Gross Margin
- 41.56%
- Op Margin
- 15.10%
- Net Margin
- 11.30%
- ROE
- 6.46%
- ROIC
- 4.51%
- Revenue
- $4.16B · -27.87%
- Net Income
- $470.53M · -55.66%
- EPS
- $0.16 · -55.56%
- Op Income
- $583.88M
- FCF YoY
- 706.91%
- 52W High
- $0.70
- 52W Low
- $0.40
- 50D MA
- $0.40
- 200D MA
- $0.40
- Beta
- 0.50
- Avg Volume
- 416.6
Get TickerSpark's AI analysis on LJUIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LJUIF coverage
Recent articles, reports, and earnings notes.
No research on LJUIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LJUIF report →Similar companies
Peers in the same neighborhood.